Effect of Sudarshan Kriya Yoga on anxiety, depression, and quality of life in people with type 2 diabetes : A pilot study in Kuwait by Shiju, Rashmi et al.
lable at ScienceDirect
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13 (2019) 1995e1999Contents lists avaiDiabetes &Metabolic Syndrome: Clinical Research & Reviews
journal homepage: www.elsevier .com/locate/dsxOriginal ArticleEffect of Sudarshan Kriya Yoga on anxiety, depression, and quality
of life in people with type 2 diabetes: A pilot study in Kuwait
Rashmi Shiju a, *, Daisy Thomas a, Monira Al Arouj a, Prem Sharma a,
Jaakko Tuomilehto b, c, Abdullah Bennakhi a
a Dasman Diabetes Institute, Kuwait
b National Institute of Health and Welfare, Helsinki, Finland
c Department of Public Health, University of Helsinki, Finlanda r t i c l e i n f o
Article history:
Received 14 April 2019
Accepted 22 April 2019
Keywords:
Yoga
Anxiety
Depression
Quality of life
T2DM
SKY* Corresponding author. Office of regulatory affairs
Al-Soor Street, Kuwait, P.O. Box 1180, Dasman, 15462
E-mail address: rashmi.shiju@dasmaninstitute.org
https://doi.org/10.1016/j.dsx.2019.04.038
1871-4021/© 2019 Diabetes India. Published by Elseva b s t r a c t
Aim: This pilot study in Kuwait was aimed to assess the effect of Sudarshan kriya yoga (SKY) on anxiety,
depression and total quality of life in people with type 2 diabetes mellitus (T2DM).
Methods: 26 T2DM patients aged greater than 30, male and female visiting the outpatient clinic of
Dasman Diabetes Institute were enrolled for the study. Pre and post 5 day SKY intervention responses of
participants on psychosocial problems were evaluated using four questionnaires (Hamilton anxiety,
patient health questionnaire (PHQ-9), Hospital anxiety depression and WHO total quality of life (QOL).
Biochemical parameters; such as lipid profile, glycated hemoglobin (HbA1c) were measured at baseline
and after 15 weeks of SKY practice.
Results: The mean age of the participants was 56.7 (±11.4 SD) years, and mean duration of diabetes 15.0
(±9.3 SD) years. Comparison of responses before and after intervention indicated a significant
improvement in the QOL, depression, anxiety and insomnia. But no significant improvement in glycemic
control.
Conclusion: Results indicate that SKY can be potentially beneficial for treating anxiety, insomnia, and
depression associated in people with T2DM and in improving the quality of life in people with T2DM.
© 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.1. Background
Diabetes mellitus is largerly affecting people across the globe
rapidly. According to the International Diabetes Federation (IDF)
atlas 8th edition, 1 in 11 adults have diabetes and almost 40 million
people in the MENA region have diabetes, the figure will rise to 86
million by 2045 if we do not act now [1]. Diabetes is a demanding
disease which requires disciplined demeanour. There is enough
evidence that depression and anxiety are relatively higher in peo-
ple with diabetes than in the general population; at least 15% have
clinical depression and it is associated with worse glycemic control
and other health problems [2]. Living with diabetes is often a
challenge to patients since it disturbs the physical and mental
health of the patient. Many seek alternative therapy in addition to
conventional medical treatment to manage it. Yoga, a mind-body, Dasman Diabetes Institute,
, Kuwait.
(R. Shiju).
ier Ltd. All rights reserved.therapy originating from India is one of the alternative therapeu-
tic intervention andwidely practiced inmany countries tomaintain
the wellness of mind, body and soul. Yoga is considered as a
wholesome approach to address the disease condition. Yoga not
only cures the physical ailments but also purifies themind, emotion
andwhole existence. Teachings of yoga is based on the concept that
sickness is not only due to physical condition but result of mental
and emotional status. Thus ailments can be eradicated from the
root by simultaneous measures taken at physical and mental level.
Sage Patanjali, who is called as father of yoga has written yoga
sutras thousands of years before in India [3]. Sudarshan Kriya Yoga
(SKY) is based on various intricate modulation of breath. It involves
repetation of certain pattern of long, short and fast inhalation and
exhalation rounds with set duration of holding a breath. Research
has demonstrated that regular practice of SKY manifest reduced
stress, improved organ function, relaxation and control of psycho-
logical and physiological states [4]. A systematic review by Mccall
on mechanism of yoga showed a positive impact of yoga on
endocrine function, nervous system, physical health, metabolism,
circulatory system, behavioral/social, inflammation, psychological
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Table 1
Demographics and anthropometric characteristics of study participants at baseline
(N¼ 26).
Characteristic N (%)
Gender
Male 13 (50.0)
Female 13 (50.0)
Nationality
Kuwaiti 13 (50.0)
Egyptian 6 (23.0)
Indian 5 (19.0)
Iranian/Other 2 (8.0)
Age in years
60 16 (61.5)
>60 10 (38.5)
Mean Age± SD (range) 56.7± 11.4 (33e78)
Mean Height (cm)± SD (range) 165.4± 9.1 (153.0e183.5)
Mean Weight (Kg)± SD (range) 83.1± 19.5 (56.5e127.0)
Mean BMI± SD (range) 30.4± 7.2 (21.8e53.6)
Mean WC (cm)± SD (range) 100.4± 14.5 (59.0e130.0)
Duration of Diabetes (year) 15.0± 9.3 (1e37)
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domized controlled trial in people with type 2 diabetes (T2DM) for
8 weeks of yoga intervention and concluded that yoga offers a
promising lifestyle intervention to decrease body weight and
potentially increases psychological well-being [6]. Another ran-
domized trial done in India by P. Jyotsna et al. on 120 people with
T2DM to assess the SKY intervention concluded a significant
improvement in quality of life (QOL), post-prandial glucose and
sympathetic cardiac autonomic function test (CAFT) in people with
T2DM practicing SKY [7]. A pre and post study by Kosuri et al.
showed a significant reduction in anxiety, general well-being
among 35 T2DM patients with 40 day yoga practice [8]. The
awareness and practice of yoga is in the nascent stage in Kuwait. To
the best of our knowledge no study has been done yet to assess the
effect of SKY among population of Kuwait which has a high prev-
alence of diabetes [9]. In this pilot study we were looking at effects
of SKY on quality of life (QOL), depression, and anxiety in people
with T2DM residing in Kuwait.
2. Methods
Recruitment and eligibility: T2DM patients from Dasman
Diabetes Institute were screened for eligibility according to the
inclusion and exclusion criteria
Inclusion criteria: People with T2DM aged 30 years and above,
scored greater than 15 (mild to severe) according to Hamilton
Anxiety Questionnaire, diagnosed with T2DM more than 1 year
ago, able to perform yoga postures, breathing exercise and un-
derstands English language as the course is delivered in English.
Exclusion criteria: People with type 1 diabetes, on antidepres-
sant drugs, bipolar disorder, pregnant, any acute coronary events in
past 6 months, on artificial pace maker, any prior spiritual medi-
tation practice or SKY within 6 months.
Study design and ethical statement: In this prospective study,
assessment was carried out at baseline and post SKY intervention
on eligible participants after obtaining written informed consent
form. The study was approved by the Ethical Review Committee of
Dasman Diabetes Institute.The study was registered under clinical
trials.gov website with number: NCT02661906.
Intervention: SKY mainly involves kriya, which is a repeatation
of breath with long, short and fast inhalation and exhalation ac-
cording to the sound ‘So-Hum’ (‘So’- inhale, ‘Hum’- exhale) played
through the recorder by the certified yoga teacher. SKY interven-
tion was provided to the enrolled participants for five days at
Dasman Diabetes Institute by certified SKY teachers. Due to cultural
taboo, male and female batch of yoga were done at separate pre-
mises on the same day with 2e4 certified yoga teachers. The
necessary requirements were provided to the enrolled participants.
A typical SKY course consists of warm up, sun salutation, asanas,
pranayama involving three stages: (bhastrika,ujjayi, alternate
nostril breathing and Sudarshan kriya), guided meditation and
corpse pose. Participants were provided with instruction manualby the certified yoga teachers as a guide to practice SKY at home
daily for 20min on the last day of the course at Dasman Diabetes
Institute.
2.1. Assessments
Effect of SKY was assessed through responses of participants on
the four questionnaires (HAM-A, total QOL, HADS and PHQ-9) at
baseline and after 5 days of SKY intervention. The main endpoint
was the mean change from pre-to post intervention on the QOL
questionnaire and the secondary endpoints were themean changes
from pre-to post intervention in HAM-A and HADS questionnaire.
Participants fasted for 12 h and visited Dasman Diabetes Insti-
tute clinic at baseline and after 15weeks of SKYpractice at home for
clinical parameter measurements. (HbA1C, total cholesterol, low
density lipoprotein, high density lipoprotein and triglycerides).
2.2. Statistical analysis
Data analysis was carried out using the Statistical Package for
Social Sciences, (IBM SPSS Statistics 25.0, IBM Corporation, Armonk,
NY, USA). Total scores and domain scores for the questionnaire data
were calculated by adding the responses of each participant. Cat-
egorical variables have been presented as numbers and percent-
ages, and continuous variables as mean and standard deviation
(SD). The paired t-test was applied to compare scores between pre
and post measures, while McNemar-Bowker test was applied to
find the association between pre and post categorical variables. The
two-tailed probability value ‘p’ < 0.05 was considered statistically
significant.
3. Results
3.1. Demographic characteristics
Table 1 summarizes demographic data of the enrolled partici-
pants. Mean age of the study sample was 56.7± 11.4 SD years and
the mean duration of the diabetes 15.0± 9.3 SD years. Equal
number of males and females participated in the study.
Quality of life, Depression and anxiety scores at baseline and
post SKY intervention.
QOL questionnaire measured 5 domain score comprising gen-
eral health, symptom botherness, emotional/mental health, diet
satisfaction and physical endurance. The total pre and post SKY
intervention scores of the participants showed a statistically
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in the score domains were (Table 2): general health 0.7 (p¼ 0.205),
symptom botherness 0.2 (p¼ 0.746), emotional/mental health 2.5
(p¼ 0.001), diet satisfaction 0.9 (p¼ 0.045) and physical endurance
2.6 (p¼ 0.011).
Significant changes were observed for the HAM-A total score
(p˂0.001), for the PHQ-9 total score (p ˂0.001) and for the HADS
total score (p¼ 0.002) (Fig. 1).
HAM-A questionnaire is a 14- item test which evaluates anxious
mood, tension, fears, insomnia and intellectual domain [10].
Anxious mood, tension, depression, somatic muscular, somatic
sensory and insomnia reported as “severe/very severe” by the
participants before SKY reduced to either “not present” or “mod-
erate” after SKY intervention. Significant improvements were
observed in the state of anxiety (p¼ 0.002), tension (p¼ 0.002),
depression (p¼ 0.029), insomnia (p¼ 0.005), somatic sensory
(p¼ 0.003) and somatic muscular (p¼ 0.010), while the responses
related to intellectual, cardiovascular symptoms, respiratory
symptoms and fear did not improve significantly (Table 3).Fig. 1. Pre and Post SKY results on anxiety, depression, quality of life.3.2. Glycemic control
Participants were instructed to practice SKYat home daily for 15
weeks. Clinical parameters measured before the intervention and
after 15 weeks did not indicate improvement. Low compliance rate
to the SKY practice at home might be the reason for insignificant
improvements. 90% of the participants did not practice SKYat home
daily as instructed during their visit at Dasman Diabetes Institute
for 15 weeks assessment.4. Discussion
Effect of yoga is extensively researched around the globe during
20th century [11]. However, to the best of our knowledge, studies to
evaluate effects associated with specially SKY on the anxiety, QOL
and depression among people with T2DM from Gulf countries are
not known. Yoga is in a preliminary stage in the State of Kuwait. In
this pilot study we attempted to assess the effect of SKY on psy-
chosocial problems in people with T2DM in Kuwait. This study
results indicated significant improvements in total quality of life in
T2DM participants which is consistent with PJyotsna et al. study [7]
where significant improvement observed in the total mean score of
QOL among the SKY practicing group in comparison with the
control group.
Similarly significant change were noted for the mean anxiety
score (HAM-A) post SKY intervention. This is consistent with the
study done by Martin Katzman et al. [10] however, the SKY inter-
vention is applied to the patients with genralized anxiety disorder
with or without comorbidities while in our study it is applied on
T2DM patients. Non-significant changes in somatic anxiety (car-
diovascular, respiratory, intellectual) may be attributed to nonTable 2
Quality of life domain scores Domain scores of QOL.
Range of score n T
P
M
General Health 3e15 26 9
Symptom botherness 3e15 26 1
Emotional/Mental Health 3e25 26 1
Diet satisfaction 2e10 26 7
Physical Endurance 4e20 26 1
p-values were generated by paired t-test.affect of SKY on these aspect. Regular practice of yoga has positive
impact on hormonal regulations thus reducing anxiety, depression,
improving pain, sleep, immune markers [4e6,8,12e14], increase in
parasympathetic activity directly influences the nervous system,
beneficial effect on cognitive function by reduction in break down
and oxygen consumption [15].
Our findings showed a significant decrease in the depression
score post SKY intervention.This is consistent with literature
[2,12,16] supporting the antidepressant effect of yoga intervention
though specifically it is not through SKY intervention.
Participants expressed that they had a very sound and satisfying
sleep after a long time with the very first practice of SKY. Out of
other symptoms of stress, insomnia is the foremost to respond to
the SKY intervention. As SKY treats the cognitive and psychody-
namic problems of an individual in relationship with the environ-
ment either external or internal [13,17].
In our pilot yoga study, there was no significant improvement in
the glycemic control in keeping with the findings of two other
studies [7,18] while some other randomized control studies re-
ported significant improvement in glycemic control [19e21]. This
variation in findings may be attributed to varying sample size,
heterogenous population, type and duration of yoga intervention
and compliance to yoga practice.
Plethora of research has been done to prove that chronic stress,
anxiety, insomnia, depression and negativemood states are directly
and proportionately associated with insulin resistance [22e26],
glucose tolerance [23,27], central obesity [28,29], dyslipidemia
[30,31], hypertension [31e33] and other components of insulin
resistance [27,34,35]. Thus there is a dire need of identifying pre-
ventive tools to combat the dreadful and epidemic T2DM. Yoga anotal score p-value
re Post Difference
ean± SD Mean± SD Mean
.1± 1.9 9.7± 1.9 0.7 0.205
0.6± 2.1 10.8± 2.1 0.2 0.746
7.5± 3.8 20.1± 2.7 2.5 0.001
.2± 2.1 8.1± 1.4 0.9 0.045
3.1± 4.4 15.7± 3.3 2.6 0.011
Table 3
HAM-A (Anxiety score) PRE AND POST ASSESSMENT.
Pre- assessment Total Post
Not present/Mild Moderate Severe/Very Severe p-value
n (%) n (%) n (%)
Anxious mood Not present/Mild 6 4 (66.7) 1 (16.7) 1 (16.7) 0.002
Moderate 5 5 (100) 0 (0) 0 (0)
Severe/Very Severe 15 9 (60.0) 6 (40) 0 (0)
Tension Not present/Mild 7 7 (100) 0 (0) 0 (0) 0.002
Moderate 5 3 (60.0) 2 (40.0) 0 (0)
Severe/Very Severe 14 10 (71.4) 2 (14.3) 2 (14.3)
Fears Not present/Mild 18 15 (83.3) 0 (0) 3 (16.7) 0.072
Moderate 6 5 (83.3)1 2 (16.7) 0 (0)
Severe/Very Severe 2 1 (50.0) 1 (50.0) 0 (0)
Insomnia Not present/Mild 7 6 (85.7) 1 (14.3) 0 (0) 0.005
Moderate 9 8 (88.9) 0 (0) 1 (11.1)
Severe/Very Severe 10 7 (70.0) 2 (20.0) 1 (10.0)
Intellectual Not present/Mild 8 5 (62.5) 2 (25.0) 1 (12.5) 0.092
Moderate 6 2 (33.3) 3 (50.0) 1 (16.7)
Severe/Very Severe 12 8 (66.7) 3 (25.0) 1 (8.3)
Post
Not present/Mild Moderate Severe/Very Severe p-value
Total n (%) n (%) n (%)
Depressed mood Not present/Mild 11 10 (90.9) 1 (9.1) 0 (0) 0.029
Moderate 5 3 (60.0) 2 (40.0) 0 (0)
Severe/Very Severe 10 6 (60.0) 2 (20.0) 2 (20.0)
Somatic/Muscular Not present/Mild 5 5 (100) 0 (0) 0 (0) 0.010
Moderate 9 6 (66.7) 1 (11.1) 2 (22.2)
Severe/Very Severe 12 4 (33.3) 5 (41.7) 3 (25.0)
Somatic/sensory Not present/Mild 7 6 (85.7) 1 (14.3) 0 (0) 0.003
Moderate 6 5 (83.3) 1 (16.7) 0 (0)
Severe/Very Severe 13 6 (46.2) 5 (38.5) 2 (15.4)
Cardiovascular symptoms Not present/Mild 12 10 (83.3) 1 (8.3) 1 (8.3) 0.160
Moderate 11 5 (45.5) 6 (54.5) 0 (0)
Severe/Very Severe 3 3 (100) 0 (0) 0 (0)
Respiratory symptoms Not present/Mild 16 13 (81.3) 2 (12.5) 1 (6.3) 0.515
Moderate 7 5 (71.4) 2 (28.6) 0 (0)
Severe/Very Severe 3 1 (33.3) 1 (33.3) 1 (33.3)
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the T2DM.
Limitation: Since this was a pilot study several limitation can be
listed. The sample size was small and no control group existed.
Moreover the data were not blinded. Thus participants might have
felt under pressure to score less after the intervention. This might
have been ruled out as there were two sets of questionnaire
requiring opposite responses post SKY intervention which partici-
pants as a layman cannot distinguish. Participants were requested
to keep a log of their yoga practice however non compliance was
observed. Similar non compliance has been reported in the study
by Lana skora-Kondza et al. [18].
5. Conclusions
This pilot study done in Kuwait, shows significant improvement
in anxiety, depression, QOL and insomnia among the people with
T2DM after SKY intervention while glycemic control and lipid
profiles did not improve significantly. This may be due to lack of
compliance to yoga practice and small sample size. Larger future
studies needs to be done to explore effects on glycemic control. SKY
may be a potential lifestyle modification for the management of the
psychosocial problems associated with T2DM.
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